Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-13

Clinical Trial Update: STAAR Visian Toric ICL Post-Approval Study [NA]

View source ↗

Summary

A post-approval study of the Visian Toric ICL for correcting myopic astigmatism has completed, with results posted on 2026-03-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Visian Toric ICL (intraocular lens (IOL))

Snippet

Sponsor: Staar Surgical Company | Conditions: Myopic Astigmatism | NA | Status: COMPLETED | Results posted: 2026-03-13